MicroRNA-Mediated Autophagy and Cardiovascular Diseases: Exploring the Crossroads of Atherosclerosis and Beyond.

Authors

Sepehr Ebrahimi-Dehkordi, Amir Hossein Barjasteh, Aida Zarei, Sina Bazmi, Sarah Vaseghi, Sara Ashna, Amirreza Solati, Ali Yousefzadeh, Bita Safarzadeh Nasrabad, Zahra Mohammadi, Hamed Haddad Kashani, Mohammad Hossein Pourhanifeh

Published in

Journal of clinical laboratory analysis. Pages e70310. Sep 07, 2026. Epub Sep 07, 2026.

Abstract

Atherosclerosis (AS) is a complex cardiovascular disease characterized by the accumulation of lipids, inflammatory cells, and fibrous materials within arterial walls. Autophagy plays a critical role in maintaining cellular homeostasis and regulating lipid metabolism in vascular cells. MicroRNAs (miRNAs), small non-coding RNA molecules involved in post-transcriptional gene regulation, have emerged as key modulators of autophagy and contributors to AS progression.
This review synthesizes current evidence on the interplay between miRNAs and autophagy in the context of AS and related cardiovascular diseases. A comprehensive literature search was conducted to identify studies investigating miRNA-mediated regulation of autophagic flux, associated molecular pathways, and their implications for vascular health and disease.
Specific miRNAs have been identified as critical regulators of autophagy in AS, influencing autophagic flux through various signaling pathways. These miRNA-mediated mechanisms contribute to lipid metabolism, inflammation, and cellular homeostasis in vascular cells, thereby affecting the initiation and progression of atherosclerotic lesions.
Elucidating the regulatory networks linking miRNAs and autophagy provides valuable insights into novel therapeutic strategies targeting aberrant miRNA-mediated autophagy. These findings highlight the potential of miRNAs as therapeutic and diagnostic targets for preventing or mitigating the development of AS and related cardiovascular diseases.

PMID:
42704033
Bibliographic data and abstract were imported from PubMed on 07 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.